Recommended reading in population pharmacokinetic pharmacodynamics
about
Understanding and applying pharmacometric modelling and simulation in clinical practice and researchPharmacokinetics of clindamycin in pregnant women in the peripartum period.Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunologyQuantifying short-term dynamics of Parkinson's disease using self-reported symptom data from an Internet social network.Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint.Nonlinear mixed-effects modelling for single cell estimation: when, why, and how to use itOverview of model-building strategies in population PK/PD analyses: 2002-2004 literature survey.Pharmacokinetic-pharmacodynamic modeling of the effect of varenicline on nicotine craving in adult smokers.Pharmacokinetics of amoxicillin in maternal, umbilical cord, and neonatal sera.The influence of labour on the pharmacokinetics of intravenously administered amoxicillin in pregnant women.Understanding the time course of pharmacological effect: a PKPD approach.Utility of a Bayesian Mathematical Model to Predict the Impact of Immunogenicity on Pharmacokinetics of Therapeutic Proteins.Population pharmacokinetics of inhaled tobramycin powder in cystic fibrosis patients.Systems Pharmacology of the NGF Signaling Through p75 and TrkA Receptors.Pharmacokinetic-Pharmacodynamic Modeling and Simulation.Measuring the glomerular filtration rate in obese individuals without overt kidney disease.
P2860
Q28468334-4CAE73D3-51AD-41A2-B2CB-4DA1CCA858A6Q33826411-DE76D3D3-3AF5-437B-8558-FF287D5B8275Q33827819-71864A2C-6C55-4930-9036-63B5BB521404Q34560102-394E6920-03D6-44DC-955F-5FD4CCADF83DQ34996894-D81ED86E-14D1-45E6-A9B1-6B8CDB88E090Q35763355-1B46CC46-7F93-4B8E-8F57-C9D6F2C75EDFQ36388088-11079896-86EF-4015-9AA0-E50C207E7A79Q36801536-187DB512-E11B-4733-AEE4-6EBAED6F801DQ37144784-17536E4A-4417-416D-827E-039F12C1998EQ37175822-6E00E3BE-C66D-4FD0-A3EB-8E10814335FEQ37832754-08026804-0110-4E0D-994F-20E60E102C32Q38790368-73E65CE4-BEB8-470D-9DE3-FB8A66019AD4Q41907045-2EDEE74D-0FC5-4066-B364-213ECDF16B61Q42110905-FA649220-8897-49BD-A35A-4DDF9B3298F6Q45841041-2114DC5B-C7F9-427B-AFA9-09193D9B57CDQ55053045-2020EF59-69B1-4A24-A679-BF03CD27247F
P2860
Recommended reading in population pharmacokinetic pharmacodynamics
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Recommended reading in population pharmacokinetic pharmacodynamics
@ast
Recommended reading in population pharmacokinetic pharmacodynamics
@en
Recommended reading in population pharmacokinetic pharmacodynamics
@nl
type
label
Recommended reading in population pharmacokinetic pharmacodynamics
@ast
Recommended reading in population pharmacokinetic pharmacodynamics
@en
Recommended reading in population pharmacokinetic pharmacodynamics
@nl
prefLabel
Recommended reading in population pharmacokinetic pharmacodynamics
@ast
Recommended reading in population pharmacokinetic pharmacodynamics
@en
Recommended reading in population pharmacokinetic pharmacodynamics
@nl
P2860
P3181
P356
P1433
P1476
Recommended reading in population pharmacokinetic pharmacodynamics
@en
P2093
Peter L Bonate
P2860
P2888
P304
P3181
P356
10.1208/AAPSJ070237
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1043836808